List of Studies ( Metabolite:N-benzylformamide)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003704 | AN006077 | Hyperglycemia leads to BMSC(bone marrow mesenchymal stromal cells) impaired osteogenesis, enhanced adipogenesis, and altered metabolism | Cultured cells | Human | Osteoporosis | University of Adelaide | LC-MS |
| ST003089 | AN005052 | Metabolome changes in embryonic CSF (Part 11) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003086 | AN005046 | Metabolome changes in embryonic CSF (Part 8) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003085 | AN005044 | Metabolome changes in embryonic CSF (Part 7) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003084 | AN005042 | Metabolic changes in embryonic CSF (Part 6) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST002966 | AN004873 | Metabolomics reveal the pathway of benzylisoquinoline alkaloids in Corydalis yanhusuo bulbs | Plant | Corydalis yanhusuo | Chongqing Academy of Chinese Materia Medica, Chongqing, China | APCIESI | |
| ST002772 | AN004512 | Day-night fluctuations in Cerebrospinal fluid metabolomics | Cerebrospinal fluid | Rat | University of Copenhagen | LC-MS | |
| ST002760 | AN004485 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney | Rat | Medical College of Wisconsin | LC-MS | |
| ST002758 | AN004475 | Metabolic responses of normal rat kidneys to a high salt intake (Plasma) | Blood | Rat | Medical College of Wisconsin | LC-MS | |
| ST002516 | AN004143 | Time course 2: Growth of Eggerthella lenta in defined media with some samples receiving 13C2 stable isotope labeled acetate | Bacterial media | Eggerthella lenta | University of California, San Francisco | LC-MS | |
| ST002399 | AN003906 | Metabolomics of Adipocyte-Conditioned Media Compared to Stromal Cell- and Un-conditioned Media | Cultured cells | Mouse | Obesity | Emory University | LC-MS |
| ST002217 | AN003626 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received 1% choline supplementation or control diet using high-resolution, high-performance LC-MS/MS analysis. | Blood | Mouse | Cancer | Wistar Institute | LC-MS |
| ST002216 | AN003625 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. | Blood | Mouse | Cancer | Wistar Institute | LC-MS |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | LC-MS |
| ST001823 | AN002959 | Alterations in the fecal microbiome and metabolome of horses with antimicrobial-associated diarrhea compared to antibiotic-treated and non-treated healthy case controls | Feces | Horse | Texas A&M University | LC-MS | |
| ST001720 | AN002803 | Metabolomics Analysis of ACTG Cohort -Update (part-II) | Blood | Human | HIV | Wistar Institute | LC-MS |
| ST001719 | AN002802 | Metabolomics Analysis of Philadelphia Cohort - Update (part-I) | Blood | Human | HIV | Wistar Institute | LC-MS |
| ST001688 | AN002756 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) | Bacterial cells | Bacteria | Stanford University | LC-MS | |
| ST001688 | AN002758 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) | Bacterial cells | Bacteria | Stanford University | LC-MS | |
| ST001671 | AN002727 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism | Bacterial cells | Bacteria | Stanford University | LC-MS | |
| ST001671 | AN002729 | A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism | Bacterial cells | Bacteria | Stanford University | LC-MS |
